SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
08 March 2024 - 4:07AM
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and
a leader in data-driven medicine, today announced Chief Financial
Officer and Chief Operating Officer, Ross Muken, will participate
in a fireside chat at the Barclays 26th Annual Global Healthcare
Conference on Wednesday, March 13, 2024, at 2:35 p.m. EDT.
The fireside chat will be webcast live on
the SOPHiA GENETICS Investor Relations website. Additionally,
a replay will be available on the website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software
company dedicated to establishing the practice of data-driven
medicine as the standard of care and for life sciences research. It
is the creator of the SOPHiA DDM™ Platform, a cloud-native platform
capable of analyzing data and generating insights from complex
multimodal data sets and different diagnostic modalities. The
SOPHiA DDM™ Platform and related solutions, products, and services
are currently used by a broad network of hospital, laboratory, and
biopharma institutions globally. For more information,
visit SOPHiAGENETICS.COM, or connect
on X, LinkedIn, Facebook,
and Instagram. Where others see
data, we see answers.
Investor ContactKellen
SangerIR@sophiagenetics.com
Media Contact Kelly
Katapodismedia@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Apr 2024 to May 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From May 2023 to May 2024